Tacey Viegas
About Tacey Viegas
Tacey Viegas serves as the Chief Operating Officer at Serina Therapeutics, Inc., bringing over 25 years of experience in drug discovery and development across various therapeutic areas. She holds a PhD in Pharmaceutical Sciences from the University of Mississippi and has previously held senior roles at BioCryst Pharmaceuticals and Nektar Therapeutics.
Current Role at Serina Therapeutics
Tacey Viegas serves as the Chief Operating Officer at Serina Therapeutics, Inc. since 2006. In this role, she oversees various operational aspects of the company, contributing to its strategic direction and management. Her tenure at Serina spans 18 years, during which she has played a significant role in advancing the company's initiatives in drug development.
Education and Expertise
Tacey Viegas holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from the University of Mississippi, which she completed from 1984 to 1988. Prior to that, she earned a Master's degree in the same field from the same institution, studying from 1982 to 1984. Additionally, she obtained a Bachelor's degree in Pharmacy from Bangalore University, studying from 1977 to 1981. Her educational background provides a strong foundation for her extensive expertise in drug discovery and development.
Professional Background
Tacey Viegas has over 25 years of experience in the pharmaceutical industry. She began her career as a Senior Scientist at R P Scherer from 1988 to 1989. She then worked as Executive Director at BioCryst Pharmaceuticals from 1994 to 2002, followed by a position as Senior Director at Nektar Therapeutics/Shearwater Polymers from 2002 to 2006. Her diverse roles have equipped her with comprehensive knowledge in managing drug development processes.
Research Contributions
Throughout her career, Tacey Viegas has made significant contributions to research, particularly in securing NIH grants aimed at developing treatments for opioid use disorders. Her involvement in this area highlights her commitment to addressing critical health challenges and advancing therapeutic solutions.
Experience in Drug Development
Tacey Viegas has extensive experience in managing and directing various aspects of drug development, including chemistry-manufacturing-controls, preclinical biology, and early development. She has also been involved in phase I safety clinical studies across multiple therapeutic areas, including oncology, pain, neurology, immunology, and anti-virals.